A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Clinical trial NCT07123415 · RECRUITING

Trial details

NCT number: NCT07123415
Sponsor: Aptabio Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Cancer Advanced Solid Tumor (Phase 1)

Start date: 2025-10-24
Primary completion: 2028-10-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.